Condensed Consolidated Statements of Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands		Cross Currency Interest Rate Contract [Member] Common Stock [Member]	Cross Currency Interest Rate Contract [Member] Additional Paid-in Capital [Member]	Cross Currency Interest Rate Contract [Member] Treasury Stock, Common [Member]	Cross Currency Interest Rate Contract [Member] Retained Earnings [Member]	Cross Currency Interest Rate Contract [Member] AOCI Attributable to Parent [Member]	Cross Currency Interest Rate Contract [Member] Parent [Member]	Cross Currency Interest Rate Contract [Member] Noncontrolling Interest [Member]	Cross Currency Interest Rate Contract [Member]	Common Stock Outstanding [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock, Common [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Parent [Member]	Noncontrolling Interest [Member]	Total
Balance (in shares) at Dec. 31, 2021										56,056
Balance at Dec. 31, 2021											$ 56	$ 1,271,925	$ 0	$ 585,209	$ (2,191)	$ 1,854,999	$ 143,462	$ 1,998,461
Stock-based compensation											0	2,814	0	0	0	2,814	0	2,814
Exercise of stock-based awards by employees and directors (*) (in shares)	[1]									16
Exercise of stock-based awards by employees and directors (*)	[1]										0	99	0	0	0	99	0	99
Cash paid to noncontrolling interest											0	0	0	0	0	0	(3,088)	(3,088)
Cash dividend declared											0	0	0	(6,727)	0	(6,727)	0	(6,727)
Net income											0	0	0	18,430	0	18,430	4,105	22,535
Change in foreign currency translation adjustments											0	0	0	0	(857)	(857)	(299)	(1,156)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment that qualifies as a cash flow hedge											0	0	0	0	3,902	3,902	0	3,902
Change in respect of derivative instruments designated for cash flow hedge		$ 0	$ 0	$ 0	$ 0	$ (1,905)	$ (1,905)	$ 0	$ (1,905)									(1,905)
Other											0	0	0	0	15	15	0	15
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)											0	0	0	0	(101)	(101)	0	(101)
Balance (in shares) at Mar. 31, 2022										56,072
Balance at Mar. 31, 2022											56	1,274,838	0	596,912	(1,137)	1,870,669	144,180	2,014,849
Balance (in shares) at Dec. 31, 2022										56,096
Balance at Dec. 31, 2022											56	1,259,072	(17,964)	623,907	2,500	1,867,571	153,404	2,020,975
Stock-based compensation											0	2,990	0	0	0	2,990	0	2,990
Exercise of stock-based awards by employees and directors (*)											0	27	0	0	0	27	0	27
Cash paid to noncontrolling interest											0	0	0	0	0	0	(2,360)	(2,360)
Cash dividend declared											0	0	0	(6,732)	0	(6,732)	0	(6,732)
Net income											0	0	0	29,029	0	29,029	4,235	33,264
Change in foreign currency translation adjustments											0	0	0	0	(306)	(306)	(390)	(696)
Change in unrealized gains or losses in respect of the Company's share in derivative instruments of unconsolidated investment that qualifies as a cash flow hedge											0	0	0	0	(1,014)	(1,014)	0	(1,014)
Change in respect of derivative instruments designated for cash flow hedge		$ 0	$ 0	$ 0	$ 0	$ (5,403)	$ (5,403)	$ 0	$ (5,403)									(5,403)
Other											0	0	0	0	14	14	0	14
Change in unrealized gains or losses on marketable securities available-for-sale (net of related tax)																		0
Issuance of common stock (in shares)										3,600
Issuance of common stock											4	297,117	0	0	0	297,121	0	297,121
Change in noncontrolling interest rights											0	1,239	0	0	0	1,239	(2,396)	(1,157)
Balance (in shares) at Mar. 31, 2023										59,696
Balance at Mar. 31, 2023											$ 60	$ 1,560,445	$ (17,964)	$ 646,204	$ (4,209)	$ 2,184,536	$ 152,493	$ 2,337,029

[1] Resulted in an amount lower than $1 thousand.